These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35900649)

  • 1. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.
    Vander Does A; Levy C; Yosipovitch G
    Am J Clin Dermatol; 2022 Sep; 23(5):647-659. PubMed ID: 35900649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRGPRX4 in Cholestatic Pruritus.
    Yu H; Wangensteen K; Deng T; Li Y; Luo W
    Semin Liver Dis; 2021 Aug; 41(3):358-367. PubMed ID: 34161994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis.
    Kamath BM; Stein P; Houwen RHJ; Verkade HJ
    Liver Int; 2020 Aug; 40(8):1812-1822. PubMed ID: 32492754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic pruritus : an update.
    De Vloo C; Nevens F
    Acta Gastroenterol Belg; 2019; 82(1):75-82. PubMed ID: 30888758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus.
    Meixiong J; Vasavda C; Snyder SH; Dong X
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10525-10530. PubMed ID: 31068464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety considerations for the management of cholestatic itch.
    Trivella J; Levy C
    Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
    Beuers U; Wolters F; Oude Elferink RPJ
    Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and Management of Pruritus in PBC and PSC.
    Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
    Kremer AE; Oude Elferink RP; Beuers U
    Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
    Schwörer H; Ramadori G
    Z Gastroenterol; 1995 May; 33(5):265-74. PubMed ID: 7610695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Cholestasis in Infants and Young Children.
    Heinz N; Vittorio J
    Curr Gastroenterol Rep; 2023 Nov; 25(11):344-354. PubMed ID: 37651067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of pruritus during cholestasis.
    Oude Elferink RP; Kremer AE; Beuers U
    Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic Itch Management.
    Mittal A
    Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestatic Pruritus in Children: Conventional Therapies and Beyond.
    Rodrigo M; Dong X; Chien D; Karnsakul W
    Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis.
    Bedoyan SM; Lovell OT; Horslen SP; Squires JE
    Expert Opin Pharmacother; 2022 Nov; 23(16):1771-1779. PubMed ID: 36278881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestatic pruritus: Emerging mechanisms and therapeutics.
    Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
    J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon?
    Sutton H; Sokol RJ; Kamath BM
    Hepatology; 2024 Jul; ():. PubMed ID: 39052914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.